C7-substituted quinazolinone and dihydroquinazolinone inhibitors of p38 map kinase.

被引:0
|
作者
Bao, JM
Miao, SW
Rupprech, KM
Pivnichny, JV
Zaller, DM
Shoop, WL
O'Neill, EA
O'Keefe, SJ
Thompson, CM
Cubbon, RM
Wang, RX
Zhang, WX
Thompson, JE
Doherty, JB
机构
[1] Merck & Co Inc, Med Chem, Rahway, NJ 07065 USA
[2] Merck & Co Inc, Dept Med Chem, Rahway, NJ 07065 USA
[3] Merck & Co Inc, Dept Inflammat Rheumatol, Rahway, NJ 07065 USA
[4] Merck & Co Inc, Dept Immunol, Rahway, NJ 07065 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
129-MEDI
引用
收藏
页码:U130 / U130
页数:1
相关论文
共 50 条
  • [21] p38 MAP kinase inhibitors: Metabolically stabilized piperidine-substituted quinolinones and naphthyridinones
    Bao, JM
    Hunt, JA
    Miao, SW
    Rupprecht, KM
    Stelmach, JE
    Liu, LP
    Ruzek, RD
    Sinclair, PJ
    Pivnichny, JV
    Hop, CECA
    Kumar, S
    Zaller, DM
    Shoop, WL
    O'Neill, EA
    O'Keefe, SJ
    Thompson, CM
    Cubbon, RM
    Wang, RX
    Zhang, WX
    Thompson, JE
    Doherty, JB
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (01) : 64 - 68
  • [22] P38 α map kinase inhibitors:: From discovery to the clinic
    Dugar, S
    Mavunkel, B
    Chakravarty, S
    Perumattam, J
    Luedtke, G
    Lu, Q
    Chen, Z
    Xu, YJ
    Protter, A
    Schreiner, G
    Almirez, R
    Scott, B
    Laney, M
    Henson, M
    Lewicki, J
    Moore, A
    Lee, S
    Brahn, E
    Liu, D
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U162 - U162
  • [23] p38 MAP kinase inhibitors: Progress, pitfalls and possibilities
    Adams, JL
    Gallagher, TF
    Boehm, JC
    Kassis, S
    Gorycki, PD
    Gum, RJ
    Webb, EF
    Sorenson, ME
    Smietana, JM
    Garigipati, RS
    Hall, RF
    Ayrton, A
    Badger, A
    Griswold, DE
    Young, PR
    Lee, JC
    [J]. MEDICINAL CHEMISTRY INTO THE MILLENNIUM, 2001, (264): : 163 - 173
  • [24] Synthesis and Evaluation of Pyridinyltriazoles as Inhibitors of p38 MAP Kinase
    Moallem, Seyed Adel
    Hadizadeh, Farzin
    Abadi, Fatemeh Abdol
    Shahraki, Mahmoud
    Shamsara, Jamal
    [J]. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2012, 15 (04) : 945 - 950
  • [25] Practical synthesis of heterocyclic p38 MAP kinase inhibitors
    Thiel, Oliver R.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [26] New generation of p38 map kinase inhibitors.
    Singh, S
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U206 - U206
  • [27] p38 MAP Kinase Inhibitors as Anti inflammatory Agents
    Amir, Mohammad
    Somakala, K.
    Ali, Sazid
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (14) : 2082 - 2096
  • [28] Oxindolylidene derivatives as p38 MAP kinase inhibitors.
    Cheng, S
    Comer, DD
    Freire-Moar, J
    Goldstein, DM
    Myers, PL
    Saunders, J
    Sjogren, EB
    Teig, S
    Warren, S
    Whiteley, PE
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U52 - U53
  • [29] MAP kinase p38 inhibitors:: Clinical results and an intimate look at their interactions with p38α protein
    Lee, MR
    Dominguez, C
    [J]. CURRENT MEDICINAL CHEMISTRY, 2005, 12 (25) : 2979 - 2994
  • [30] Phenylephrine stimulation of growth in adult cardiomyocytes is dependent upon p38 MAP kinase.
    Davies, A
    Taylor, PM
    Proud, CG
    [J]. FASEB JOURNAL, 2000, 14 (04): : A583 - A583